No Data
No Data
Virpax Says It Is Looking To Use Molecular Envelope Technology Or A Similar Technology To Deliver An MRNA COVID
Express News | Virpax Looking to Use Met to Develop Intranasal Covid Vaccine
Virpax Looking to Use MET to Develop Intranasal COVID Vaccine
Maxim Group Maintains Virpax Pharmaceuticals(VRPX.US) With Hold Rating
Analysts Conflicted on These Healthcare Names: Clearside Biomedical (CLSD) and Virpax Pharmaceuticals (VRPX)
Virpax's NES100 to Be Presented at The Society of Toxicology by NCATS
J L 7 2 : Now we are waiting for the price of RS. Good luck.